Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 miR-21 and RECK expression data in the malignant prostatic tissue according to Gleason score, Pathological stage, PSA value and Biochemical Recurrence

From: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

  miR-21 RECK
Gleason Score   
< 7 (n = 22) 0.63 0.88
≥ 7 (n = 31) 0.81 2.10
p-value 0.545 0.214
Pathological Stage   
pT2 (n = 22) 0,36 1.18
pT3 (n = 30) 1,01 1.85
p-value 0.009 0.470
PSA value   
<10 (n = 27) 0.68 0.94
≥10 (n = 26) 0.80 2.18
p-value 0.701 0.390
Biochemical Recurrence   
W/n (n = 27) 0.52 1.05
With (n = 20) 1.12 2.61
p-value 0.051 0.366
  1. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 2-ΔΔCT).